V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20225385 | 20085117 | 1.7 | 64.9 | Curative (C) | 2017-11-07 | 2017-11-15 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | ECF | 100191215 |
| 20225403 | 20085118 | 1.73 | 64.7 | Adjuvant (A) | null | 2019-09-11 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 101499739 |
| 20225408 | 20085119 | 1.68 | 67 | Curative (C) | 2017-08-02 | 2017-08-15 | Enzalutamide | 02 | N | ECF | 100818110 |
| 20225410 | 20085120 | 1.6 | 107.8 | Palliative (P) | 2012-02-22 | 2018-05-25 | Enzalutamide | 02 | N | TRASTUZUMAB | 100019995 |
| 20225412 | 20085121 | 1.59 | 62.5 | Palliative (P) | 2017-01-18 | 2017-01-18 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101388647 |
| 20225420 | 20085122 | 1.49 | 97.1 | Curative (C) | 2017-01-29 | 2017-01-29 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100777886 |
| 20225422 | 20085123 | 1.75 | 88.7 | Curative (C) | 2018-12-25 | 2018-12-26 | Enzalutamide | 02 | null | OXALIPLATIN + RALTITREXED | 101376154 |
| 20225424 | 20085124 | 1.68 | 85.7 | null | 2017-06-08 | 2017-06-22 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100644522 |
| 20225427 | 20085125 | 1.63 | 85.4 | Palliative (P) | 2016-04-20 | 2016-04-20 | Capecitabine + Cisplatin + RT | 02 | N | CETUXIMAB | 101353854 |
| 20225428 | 20085126 | 1.82 | 81.4 | Curative (C) | 2016-04-04 | 2016-04-11 | Enzalutamide | 02 | Y | CARBOPLATIN + GEMCITABINE | 100392811 |
| 20225430 | 20085127 | 1.86 | 66.3 | Palliative (P) | 2019-03-18 | 2019-03-18 | ECF | 02 | N | CISPLATIN | 100749032 |
| 20225434 | 20085128 | 1.6 | 72.8 | Disease modification (D) | 2017-07-22 | 2017-08-12 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 101108627 |
| 20225436 | 20085129 | 1.64 | 64.6 | Palliative (P) | 2019-06-28 | 2019-07-20 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100949727 |
| 20225441 | 20085130 | 1.6 | 60.7 | Palliative (P) | null | 2016-02-18 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101477818 |
| 20225444 | 20085131 | 1.74 | null | Palliative (P) | 2016-12-25 | 2016-12-29 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100576733 |
| 20225451 | 20085132 | 1.47 | 84.85 | Neo-adjuvant (N) | 2019-06-19 | 2019-07-09 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN + RT | 100015930 |
| 20225454 | 20085133 | 1.67 | 61 | Neo-adjuvant (N) | 2018-02-20 | 2018-02-23 | CARBOPLATIN + PACLITAXEL + RT | N | Y | CARBOPLATIN + PACLITAXEL + RT | 101478666 |
| 20225456 | 20085134 | null | 58.9 | null | 2016-08-31 | 2016-09-17 | Cetuximab 14 day | 99 | null | CETUXIMAB + OXALIPLATIN + MDG | 101682503 |
| 20225459 | 20085135 | 1.62 | 81.75 | Palliative (P) | 2016-07-13 | 2016-07-13 | Enzalutamide | 02 | N | TRASTUZUMAB | 101817266 |
| 20225465 | 20085136 | 1.67 | 59.2 | Palliative (P) | 2018-05-29 | 2018-06-10 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100496517 |
| 20225488 | 20085137 | 1.71 | 74.4 | Neo-adjuvant (N) | 2018-05-27 | 2018-06-06 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101544896 |
| 20225489 | 20085138 | null | null | Palliative (P) | 2017-08-23 | 2017-09-23 | Cetuximab 14 day | 02 | N | CARBOPLATIN + GEMCITABINE | 100691874 |
| 20225492 | 20085139 | 1.73 | 92.1 | Curative (C) | 2018-05-25 | 2018-05-27 | Enzalutamide | 2 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101329069 |
| 20225495 | 20085140 | 1.66 | 68 | Curative (C) | 2017-05-14 | 2017-05-21 | Enzalutamide | 02 | N | CISPLATIN | 101153510 |
| 20225499 | 20085141 | 1.62 | 54.5 | Palliative (P) | 2016-05-15 | 2016-05-22 | Enzalutamide | 2 | N | CETUXIMAB | 101811217 |
| 20225505 | 20085142 | 1.52 | 94.2 | Palliative (P) | 2016-07-14 | 2016-07-14 | Cetuximab 14 day | null | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100249879 |
| 20225511 | 20085143 | 1.8 | 69.5 | Neo-adjuvant (N) | 2019-05-03 | 2019-05-18 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100819028 |
| 20225529 | 20085144 | 1.54 | 85.6 | Palliative (P) | 2017-09-27 | 2017-10-05 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100931232 |
| 20225536 | 20085145 | 1.65 | 71 | Curative (C) | 2020-01-24 | 2020-01-28 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101263137 |
| 20225538 | 20085146 | 1.76 | 78 | Neo-adjuvant (N) | 2017-01-23 | 2017-01-30 | Enzalutamide | N | N | CARBOPLATIN + GEMCITABINE | 101855007 |
| 20225539 | 20085147 | 1.64 | 65.5 | Palliative (P) | 2018-03-31 | 2018-04-02 | Trastuzumab | N | N | TRASTUZUMAB | 100558934 |
| 20225540 | 20085148 | 1.76 | 87.9 | Palliative (P) | 2017-04-12 | 2017-04-12 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101664124 |
| 20225542 | 20085149 | 1.67 | 58.8 | Palliative (P) | 2016-08-23 | 2016-08-23 | Enzalutamide | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100226237 |
| 20225543 | 20085150 | null | 58 | Palliative (P) | 2018-04-13 | 2018-05-23 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | ECF | 101473689 |
| 20225546 | 20085151 | 1.78 | 70.4 | Palliative (P) | 2017-07-16 | 2017-07-17 | Enzalutamide | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100873954 |
| 20225547 | 20085152 | 1.72 | 77 | Neo-adjuvant (N) | 2016-07-07 | 2016-07-07 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101750304 |
| 20225550 | 20085153 | 1.6 | 50.7 | Curative (C) | 2016-03-20 | 2016-04-08 | Capecitabine + Cisplatin + RT | 2 | Y | CAPECITABINE + CISPLATIN + RT | 101043004 |
| 20225556 | 20085154 | 1.52 | 61.2 | Curative (C) | 2019-08-18 | 2019-08-29 | Enzalutamide | 02 | N | TRASTUZUMAB | 101585012 |
| 20225560 | 20085155 | 1.73 | 0 | Neo-adjuvant (N) | 2020-07-31 | 2020-07-31 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100347090 |
| 20225562 | 20085156 | 1.67 | 51.6 | null | 2017-05-01 | 2017-05-02 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB | 100346891 |
| 20225569 | 20085157 | 1.74 | 98 | Palliative (P) | 2018-08-16 | 2018-08-16 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100518918 |
| 20225571 | 20085158 | 1.66 | 86 | null | 2016-05-20 | 2016-05-20 | Enzalutamide | 02 | null | OXALIPLATIN + RALTITREXED | 101565895 |
| 20225573 | 20085159 | 1.7 | 61.6 | Adjuvant (A) | 2020-01-18 | 2020-02-06 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100722427 |
| 20225590 | 20085160 | 0 | null | Palliative (P) | null | 2017-07-24 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101588476 |
| 20225592 | 20085161 | 0 | 0 | 03 | 2018-12-15 | 2018-12-15 | Enzalutamide | 02 | N | CETUXIMAB | 101312970 |
| 20225601 | 20085162 | 1.72 | 88.9 | Palliative (P) | 2015-03-04 | 2015-03-05 | ECF | 02 | N | CETUXIMAB | 100890865 |
| 20225612 | 20085163 | null | 65.9 | Neo-adjuvant (N) | 2019-11-05 | 2019-11-05 | Enzalutamide | 02 | Y | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100507823 |
| 20225613 | 20085164 | 1.62 | 62.8 | null | 2017-11-02 | 2017-11-02 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101189455 |
| 20225614 | 20085165 | 1.65 | 71.3 | Neo-adjuvant (N) | 2016-02-05 | 2016-03-06 | Enzalutamide | 02 | N | CARBOPLATIN | 101519629 |
| 20225618 | 20085166 | 1.71 | 86 | 03 | null | 2019-05-29 | Enzalutamide | 02 | Y | ENZALUTAMIDE | 100449336 |